Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: an analysis of a nationwide survey
Yoshitaka Murakami, Yuji Nishiwaki, Mari S. Oba, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 12, pp. 1070-1077
Closed Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

The four epidemiological stages in the global evolution of inflammatory bowel disease
Gilaad G. Kaplan, Joseph W. Windsor
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 1, pp. 56-66
Open Access | Times Cited: 840
Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, et al.
Journal of Gastroenterology (2018) Vol. 53, Iss. 3, pp. 305-353
Open Access | Times Cited: 630
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, et al.
Journal of Gastroenterology (2021) Vol. 56, Iss. 6, pp. 489-526
Open Access | Times Cited: 354
Incidence and Prevalence of Inflammatory Bowel Disease across Asia
Jihye Park, Jae Hee Cheon
Yonsei Medical Journal (2021) Vol. 62, Iss. 2, pp. 99-99
Open Access | Times Cited: 129
Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
Shu‐Chen Wei, Jose D. Sollano, Yee Tak Hui, et al.
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 3, pp. 275-289
Closed Access | Times Cited: 70
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study
Shinichiro Shinzaki, Katsuyoshi Matsuoka, Hiroki Tanaka, et al.
Journal of Gastroenterology (2021) Vol. 56, Iss. 6, pp. 560-569
Open Access | Times Cited: 57
Evolving Trends and Burden of Inflammatory Bowel Disease in Asia, 1990–2019: A Comprehensive Analysis Based on the Global Burden of Disease Study
Xuejie Chen, Xin Xiang, Weitong Xia, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 725-739
Open Access | Times Cited: 28
Inflammatory Bowel Disease and Sarcopenia: Its Mechanism and Clinical Importance
Hiroki Nishikawa, Shirô Nakamura, Takako Miyazaki, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4214-4214
Open Access | Times Cited: 53
The role of endoplasmic reticulum stress in regulation of intestinal barrier and inflammatory bowel disease
Yue-Rong Tan, Si-Yang Shen, Haiqing Shen, et al.
Experimental Cell Research (2023) Vol. 424, Iss. 1, pp. 113472-113472
Closed Access | Times Cited: 17
Comparison of Endoscopic and Artificial Intelligence Diagnoses for Predicting the Histological Healing of Ulcerative Colitis in a Real-World Clinical Setting
Teppei Omori, Tomoko Yamamoto, Shun Murasugi, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016
Katsuyoshi Matsuoka, Ataru Igarashi, Noriko Sato, et al.
Journal of Crohn s and Colitis (2020) Vol. 15, Iss. 3, pp. 358-366
Open Access | Times Cited: 49
Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase
Life (2021) Vol. 11, Iss. 12, pp. 1375-1375
Open Access | Times Cited: 36
Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn’s Disease: A Phase 3 Study
Satomi Furukawa, Tsunekazu Mizushima, R Nakaya, et al.
Journal of Crohn s and Colitis (2022) Vol. 17, Iss. 3, pp. 369-378
Open Access | Times Cited: 27
Trends in the prevalence and incidence of ulcerative colitis in Japan and the US
Michiyo Yamazaki, Hsingwen Chung, Youran Xu, et al.
International Journal of Colorectal Disease (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis
Sakiko Hiraoka, Akiko Fujiwara, Tatsuya Toyokawa, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 36, Iss. 1, pp. 137-143
Closed Access | Times Cited: 34
Association between allergic diseases and mucosal healing in ulcerative colitis
Yasunori Yamamoto, Shinya Furukawa, Osamu Yoshida, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Designing Effective Protocol-Based Pharmacotherapy Management: Assessment of the Development Processes and Outcomes in Inflammatory Bowel Disease Care Prescription Management
Masatsugu Sato, Shigeru Fujita, Masahiko Kimura, et al.
Pharmacy (2025) Vol. 13, Iss. 1, pp. 17-17
Open Access
Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn’s Disease: Results from the Japanese CONFIDE Study
Toshifumi Hibi∥, Taku Kobayashi, Masaru Tanaka, et al.
Advances in Therapy (2025)
Open Access
Impact of therapeutic agents on serum leucine-rich alpha-2 glycoprotein for monitoring endoscopically remitted ulcerative colitis
Junnosuke Hayasaka, Akira Matsui, Daisuke Kikuchi, et al.
Research Square (Research Square) (2025)
Closed Access
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease
Yuya Ogino, Kento Sadashima, Yuichiro Yoshida, et al.
Journal of Gastroenterology (2025)
Closed Access
Influence of preoperative anti TNF alpha antibody therapy on postoperative recurrence of Crohn’s disease
Yuki Sekido, Takayuki Ogino, Takashi Takeda, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
Kenji Watanabe
Intestinal Research (2020) Vol. 18, Iss. 4, pp. 347-354
Open Access | Times Cited: 29
Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 11, pp. 867-878
Closed Access | Times Cited: 18
Serum leucine‐rich alpha‐2 glycoprotein and calprotectin in children with inflammatory bowel disease: A multicenter study in Japan
Ryosuke Yasuda, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 7, pp. 1131-1139
Closed Access | Times Cited: 9
Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018
Seulji Kim, Hyun Jung Lee, Seung Woo Lee, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1154-1163
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top